Status:
UNKNOWN
Early and Midterm Outcomes of Intravascular Ultrasound (IVUS) Versus Non-IVUS Guidance in Complex Coronary Chronic Total Occlusion (CTO) Revascularization.
Lead Sponsor:
Assiut University
Conditions:
Chronic Total Occlusion of Coronary Artery
Eligibility:
All Genders
Phase:
NA
Brief Summary
Various CTO percutaneous coronary intervention (PCI) studies defined CTO as as a substantial atherosclerotic blockage with \>3 months duration of TIMI (Thrombolysis in Myocardial Infarction) 0 flow ot...
Eligibility Criteria
Inclusion
- \- All coronary CTO patients in whom coronary anatomy is defined by coronary CT and/or Coronary angiography provided that:- CTO defined as heavy atherosclerotic occlusion with TIMI (Thrombolysis in Myocardial Infarction) 0 flow other than via collaterals for \>3 months and they are symptomatic despite optimal medical therapy and/or positive high risk stress modality.
Exclusion
- Acute coronary syndrome within 3 months.
- Patients with renal insufficiency (eGFR \< 60 ml/kg/m2, serum creatinine ≥ 2.5 mg/dL, or on regular dialysis).
- Patients with expected post CTO-PCI procedure SYNTAX \>10.
- Hemodynamically unstable patients.
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04917432
Start Date
September 1 2022
End Date
September 30 2025
Last Update
June 8 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.